Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: Comparison of prehospital tirofiban versus fibrinolysis before direct PCI

International Journal of Cardiology

Volumn 103, Issue 2, 2005, Pages 193-200

  Möckel, Martin ^a   Bocksch, Wolfgang ^a   Strohm, Sebastian ^a   Kühnle, York ^a   Vollert, Jörn ^a   Nibbe, Lutz ^a   Dietz, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Facilitated direct PCI; Fibrinolysis; ST elevation myocardial infarction; Tirofiban

Indexed keywords

ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING TENDENCY; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DATA ANALYSIS; DRUG FATALITY; FEMALE; FIBRINOLYSIS; HEART DEATH; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; LONG TERM CARE; LUNG HEMORRHAGE; MALE; ONSET AGE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CREATINE KINASE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PREOPERATIVE CARE; RECOMBINANT PROTEINS; RESEARCH DESIGN; STREPTOKINASE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TYROSINE;

EID: 23244436971     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.10.015     Document Type: Article

References (19)

1. F. Van de Werf, D. Ardissino, A. Betriu, D.V. Cokkinos, E. Falk, and K.A. Fox Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology Eur Heart J 24 1 2003 28 66
2. H.R. Andersen, T.T. Nielsen, K. Rasmussen, L. Thuesen, H. Kelbaek, and P. Thayssen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 8 2003 733 742
3. P. Widimsky, T. Budesinsky, D. Vorac, L. Groch, M. Zelizko, and M. Aschermann Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2 Eur Heart J 24 1 2003 94 104
4. G.W. Stone, D. Cox, E. Garcia, B.R. Brodie, M.C. Morice, and J. Griffin Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials Circulation 104 6 2001 636 641
5. B.R. Brodie, T.D. Stuckey, T.C. Wall, G. Kissling, C.J. Hansen, and D.B. Muncy Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 32 5 1998 1312 1319
6. C.P. Cannon, C.M. Gibson, C.T. Lambrew, D.A. Shoultz, D. Levy, and W.J. French Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 22 2000 2941 2947
7. E.J. Topol Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial Lancet 357 9272 2001 1905 1914
8. G. Montalescot, P. Barragan, O. Wittenberg, P. Ecollan, S. Elhadad, and P. Villain Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 25 2001 1895 1903
9. D.P. Lee, N.A. Herity, B.L. Hiatt, W.F. Fearon, M. Rezaee, and A.J. Carter Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial Circulation 107 11 2003 1497 1501
10. G.B. Danzi, C. Capuano, M. Sesana, and R. Baglini Safety of a high bolus dose of tirofiban in patients undergoing coronary stent placement Catheter Cardiovasc Interv 61 2 2004 179 184
11. E.G. Bovill, M.L. Terrin, D.C. Stump, A.D. Berke, M. Frederick, and D. Collen Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Ann Intern Med 115 4 1991 256 265
12. C.M. Gibson, C.P. Cannon, W.L. Daley, J.T. Dodge Jr., B. Alexander, and S.J. Marble TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 5 1996 879 888
13. C.P. Cannon, C.M. Gibson, C.H. McCabe, A.A.J. Adgey, M.J. Schweiger, and R.F. Sequeira TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial Circulation 98 25 1998 2805 2814
14. A.W.J. van't Hof, N. Ernst, M.J. de Boer, R. de Winter, E. Boersma, and T. Bunt Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial Eur Heart J 25 10 2004 837 846
15. C.M. Gibson, C.P. Cannon, S.A. Murphy, S.J. Marble, H.V. Barron, and E. Braunwald Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation 105 16 2002 1909 1913
16. A.M. Ross, K.S. Coyne, J.S. Reiner, S.W. Greenhouse, C. Fink, and A. Frey A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial J Am Coll Cardiol 34 7 1999 1954 1962
17. L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A.J. Adgey, and H.R. Arntz Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2 2003 135 142
18. ASSENT-2 Investigators Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Lancet 354 9180 1999 716 722
19. R. Zahn, R. Schiele, S. Schneider, A.K. Gitt, T. Heer, and H. Wienbergen Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial Z Kardiol 91 1 2002 49 57